Dr. Lockhart is a neuroscientist and neuroimager with 20+ years’ experience in clinical trials of late-life brain health, focusing on cognition, imaging, and associated biomarkers. With 100+ publications and work with multiple NIH ADRCs, he co-leads CNS-focused scientific operations, strategy and business development at Perceptive Imaging.
Leading the strategic development of CNS focused offerings in Perceptive, including new read approaches and analysis pipelines.
100+ peer reviewed publications.
Adjunct Associate Professor at Wake Forest University School of Medicine
Co-founder of an ADRC Neuroimaging Core
Leadership positions in Alzheimer’s Association ISTAART Neuroimaging Professional Interest Area (2025-26 Programs chair and incoming Vice-Chair)
Plasma and neuroimaging biomarkers of small vessel disease and Alzheimer’s disease in a diverse cohort: MESA
PET Imaging of Tau Deposition in the Aging Human Brain: Neuron
Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer’s disease neuropathology
Associations among plasma, MRI, and amyloid PET biomarkers of Alzheimer’s disease and related dementias and the impact of health-related comorbidities in a community-dwelling cohort
Amyloid and tau PET demonstrate region-specific associations in normal older people
Structural Imaging Measures of Brain Aging
